Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 310.62 Million | 264.19 Million | 247.07 Million | 120.68 Million | 293.46 Million | 436.27 Million |
| Cost of Revenue | 171.1 Million | 122.93 Million | 83.46 Million | 43.3 Million | 75.55 Million | 188.8 Million |
| Gross Profit | 139.51 Million | 141.25 Million | 163.61 Million | 77.37 Million | 217.9 Million | 247.46 Million |
| Operating Expenses | 120.89 Million | 165.21 Million | 176.55 Million | 149.33 Million | 184.54 Million | 174.16 Million |
| Selling, General and Administrative Expenses | 95.4 Million | 112.41 Million | 127.18 Million | 97.77 Million | 146.04 Million | 135.84 Million |
| Research and Development Expenses | 27.52 Million | 23.5 Million | 21.41 Million | 25.67 Million | 17.58 Million | 16.23 Million |
| Other Expenses | -5.98 Million | 29.29 Million | 27.95 Million | 25.88 Million | 20.91 Million | -2.4 Million |
| Cost and Expenses | 288.06 Million | 288.15 Million | 260.01 Million | 192.64 Million | 260.1 Million | 362.97 Million |
| Operating Income | 22.56 Million | -6.55 Million | 3.33 Million | -71.96 Million | 32.49 Million | 70.19 Million |
| Interest Expense | 6.9 Million | 8.08 Million | 6.59 Million | 5.72 Million | 1.42 Million | 218.85 Thousand |
| Income Tax Expense | 12.82 Million | 7.64 Million | 9.57 Million | 18.39 Million | 4.74 Million | 9.09 Million |
| Earnings before Tax | 22.35 Million | -29.67 Million | -13.76 Million | -48.82 Million | 32.22 Million | 70 Million |
| Net Income | 9.53 Million | -37.31 Million | -23.34 Million | -67.22 Million | 27.48 Million | 60.9 Million |
| Earnings Per Share Basic | 0.05 | -0.21 | -0.13 | -0.38 | 0.16 | 0.35 |
| Earnings Per Share Diluted | 0.05 | -0.21 | -0.13 | -0.38 | 0.16 | 0.35 |
| Weighted Average Shares Outstanding | 175.89 Million | 176 Million | 176 Million | 176 Million | 176 Million | 175.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 175.89 Million | 176 Million | 176 Million | 176 Million | 176 Million | 175.97 Million |
| Gross Margin | 0.45 | 0.53 | 0.66 | 0.64 | 0.74 | 0.57 |
| EBIT Margin | 0.20 | 0.10 | 0.15 | -0.09 | 0.19 | 0.21 |
| Profit Margin | 0.03 | -0.14 | -0.09 | -0.56 | 0.09 | 0.14 |
| EBITDA | 62.39 Million | 12.55 Million | 25.69 Million | -13.43 Million | 54 Million | 84.44 Million |
| Earnings Before Tax Margin | 0.07 | -0.02 | 0.01 | -0.60 | 0.11 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 61.46 Million | 85.45 Million | 69.48 Million | 85.24 Million | 310.62 Million | 68.59 Million |
| Cost of Revenue | 36.29 Million | 45.46 Million | 41.87 Million | 56.59 Million | 167.16 Million | 36.89 Million |
| Gross Profit | 25.16 Million | 39.98 Million | 27.61 Million | 28.64 Million | 143.46 Million | 31.69 Million |
| Operating Expenses | 28.49 Million | 38.45 Million | 22.4 Million | 15.73 Million | 129.81 Million | 32.88 Million |
| Selling, General and Administrative Expenses | 22.19 Million | 32.34 Million | 16.6 Million | -15.13 Million | - | 39.16 Million |
| Research and Development Expenses | 7.22 Million | 4.98 Million | 5.34 Million | 5.69 Million | - | 6.69 Million |
| Other Expenses | -6.29 Million | -1.12 Million | -40.04 Thousand | 233.77 Thousand | -210.05 Thousand | -4.51 Million |
| Cost and Expenses | 64.78 Million | 83.91 Million | 64.27 Million | 72.33 Million | 296.97 Million | 69.78 Million |
| Operating Income | -3.32 Million | 1.53 Million | 2.17 Million | 11.16 Million | 22.56 Million | 3.82 Million |
| Interest Expense | 2.02 Million | 1.46 Million | 1.48 Million | 1.76 Million | 6.9 Million | 1.71 Million |
| Income Tax Expense | 97.07 Thousand | 118.72 Thousand | 513.05 Thousand | 6.18 Million | 12.82 Million | 2.19 Million |
| Earnings before Tax | -5.36 Million | 259.31 Thousand | 2.13 Million | 11.39 Million | 22.35 Million | 3.52 Million |
| Net Income | -5.45 Million | 140.59 Thousand | 1.62 Million | 5.2 Million | 9.53 Million | 1.33 Million |
| Earnings Per Share Basic | -0.03 | 0.00 | 0.01 | 0.03 | - | 0.01 |
| Earnings Per Share Diluted | -0.03 | 0.00 | 0.01 | 0.03 | - | 0.01 |
| Weighted Average Shares Outstanding | 176 Million | 176 Million | 176.53 Million | 176.25 Million | 175.89 Million | 176 Million |
| Weighted Average Shares Outstanding (Diluted) | 176 Million | 176 Million | 176.53 Million | 176.25 Million | 175.89 Million | 176 Million |
| Gross Margin | 0.41 | 0.47 | 0.40 | 0.34 | 0.46 | 0.46 |
| EBIT Margin | -0.05 | 0.12 | 0.08 | 0.16 | - | -0.08 |
| Profit Margin | -0.09 | 0.00 | 0.02 | 0.06 | 0.03 | 0.02 |
| EBITDA | -3.33 Million | 9.85 Million | 5.25 Million | 13.28 Million | - | -5.46 Million |
| Earnings Before Tax Margin | -0.05 | 0.02 | 0.03 | 0.13 | 0.07 | 0.06 |
4557
PNFPP
2778
2061
3141
HMVL